SNDX
Syndax Pharmaceuticals Inc
NASDAQ: SNDX · HEALTHCARE · BIOTECHNOLOGY
$20.65
+2.74% today
Updated 2026-05-06
Market cap
$1.69B
P/E ratio
—
P/S ratio
7.79x
EPS (TTM)
$-2.79
Dividend yield
—
52W range
$9 – $26
Volume
1.6M
Syndax Pharmaceuticals Inc (SNDX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+2.8%
Last 4 quarters
Revenue YoY growth
+791.7%
Most recent quarter
EPS YoY growth
+29.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+15.8%
Last 3 reports
Positive reaction rate
100%
3 of 3 quarters
Largest single-day move
+26.0%
2025-08-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-09 | $-0.78 | -33.2% | $22.07 | $24.16 | +9.5% |
| 2025-11-03 | $-0.70 | +4.1% | $13.70 | $15.35 | +12.0% |
| 2025-08-04 | $-0.83 | +17.8% | $9.98 | $12.57 | +26.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.59 | $-0.78 | -33.2% | $68.48M | +791.7% |
| 2025-09-30 | $-0.73 | $-0.70 | +4.1% | $45.87M | +267.0% |
| 2025-06-30 | $-1.01 | $-0.83 | +17.8% | $37.96M | +984.5% |
| 2025-03-31 | $-1.27 | $-0.98 | +22.7% | $20.04M | — |
| 2024-12-31 | $-0.23 | $-1.10 | -380.6% | $7.68M | +1332.8% |
| 2024-09-30 | $-1.11 | $-0.98 | +11.7% | $12.50M | — |
| 2024-06-30 | $-0.91 | $-0.80 | +12.1% | $3.50M | — |
| 2024-03-31 | $-0.98 | $-0.85 | +13.3% | — | — |
| 2023-12-31 | $-0.99 | $-1.00 | -1.0% | $536000.00 | — |
| 2023-09-30 | $-0.80 | $-0.73 | +8.8% | — | — |
| 2023-06-30 | $-0.73 | $-0.64 | +12.3% | — | — |
Frequently asked questions
Has Syndax Pharmaceuticals Inc beaten earnings estimates?
Syndax Pharmaceuticals Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +2.8% over the last 4 quarters.
How does SNDX stock react to earnings?
SNDX stock has moved an average of +15.8% in the trading day following earnings over its last 3 reports, with positive reactions in 100% of those quarters.
What is Syndax Pharmaceuticals Inc's revenue growth rate?
Syndax Pharmaceuticals Inc reported year-over-year revenue growth of +791.7% in its most recent quarter, with EPS growing +29.1% year-over-year.